Evaluation of Chloropentafluorobenzene as an Intake Simulant for Chemical Defense Training
Abstract
For a number of years the U.S. Air Force has been performing research to develop safe intake simulants for chemical warfare agents (CWA) to provide accurate and quantitative real-time assessment of troop proficiency and gear efficacy during chemical warfare (CW) field exercises. Chloropentafluorobenzene (CPFB) was identified and evaluated as a candidate inhalation simulant, and was determined to possess desirable physiochemical and toxicological properties. These include rapid uptake, low metabolism and toxicity, rapid and predictable clearance, real-time detectability by existing portable 'breathalyzer' technology and by fielded CWA detectors, realistic canister breakthrough and commercial availability. A physiologically based pharmacokinetic (PBPK) model for CPEB has been developed which accurately describes the time course of blood and exhaled air concentrations during and following inhalation exposures of rats and primates to CPFB. This model has been employed to predict human exhaled air concentrations for several hours following brief CPFB exposures, such as might be experienced in training exercises using CPFB as an intake simulant. These simulants could be used to determine the exhaled air concentrations at which personnel would have been incapacitated had the exposure been to a real agent. The PBPK model was also used to calculate internal dose measures for a quantitative assessment of safe exposure criteria for the use of CPFB in such exercises. To assure the safety of personnel it is recommended that field exercises be designed to avoid exposures greater than 30 parts per million (ppm) , with the daily (8 h) time-weighted average not to exceed 3 ppm. The exposure guideline should not impair use of CPFB since field analytical methods can measure CPFB at part per trillion levels.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jan 01, 1993
- Accession Number
- ADA272616
Entities
People
- B. M. Jarnot
- H. J. Clewell Iii